These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 8352384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.
    Edstein MD, Bahr S, Kotecka B, Shanks GD, Rieckmann KH.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2300-1. PubMed ID: 9333069
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M, Schreiber J, Ehrhardt S, Otchwemah R, Jelinek T, Bienzle U, Mockenhaupt FP.
    Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
    [Abstract] [Full Text] [Related]

  • 6. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
    Kinyanjui SM, Mberu EK, Winstanley PA, Jacobus DP, Watkins WM.
    Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model.
    Rieckmann KH, Yeo AE, Edstein MD.
    Trans R Soc Trop Med Hyg; 1996 Jun; 90(5):568-71. PubMed ID: 8944276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro.
    Yeo AE, Rieckmann KH.
    Ann Trop Med Parasitol; 1997 Apr; 91(3):247-51. PubMed ID: 9229018
    [Abstract] [Full Text] [Related]

  • 11. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
    Fidock DA, Nomura T, Wellems TE.
    Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
    [Abstract] [Full Text] [Related]

  • 12. Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone.
    Yeo AE, Edstein MD, Rieckmann KH.
    Acta Trop; 1997 Sep 30; 67(3):207-14. PubMed ID: 9241385
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.
    Edstein MD, Yeo AE, Kyle DE, Looareesuwan S, Wilairatana P, Rieckmann KH.
    Trans R Soc Trop Med Hyg; 1996 Sep 30; 90(4):418-21. PubMed ID: 8882194
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM, Gupta S, Spindler C, Wernsdorfer WH, Björkman A.
    Trans R Soc Trop Med Hyg; 2003 Sep 30; 97(3):331-7. PubMed ID: 15228254
    [Abstract] [Full Text] [Related]

  • 16. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K, Scott L.
    Drugs; 2003 Sep 30; 63(6):597-623. PubMed ID: 12656656
    [Abstract] [Full Text] [Related]

  • 17. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
    Hekmat-Nejad M, Rathod PK.
    Exp Parasitol; 1997 Nov 30; 87(3):222-8. PubMed ID: 9371087
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M, Gutteridge W, Zeman A, Dickins M, Woolley JL.
    J Travel Med; 1999 May 30; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [Abstract] [Full Text] [Related]

  • 20. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
    Watkins WM, Sixsmith DG, Chulay JD.
    Ann Trop Med Parasitol; 1984 Jun 30; 78(3):273-8. PubMed ID: 6385887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.